Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Quality of Life (QoL) and Symptoms in Patients With Polycythemia Vera (PV) Receiving Ruxolitinib (Ruxo) in a Routine Clinical Practice

NCT05566535 is registered in ClinicalTrials.gov with Multinational Center for Quality of Life Research, Russia as lead sponsor.

NCT NCT05566535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Quality of Life (QoL) and Symptoms in Patients With Polycythemia Vera (PV) Receiving Ruxolitinib (Ruxo) in a Routine Clinical Practice
Lead sponsor
Multinational Center for Quality of Life Research, Russia
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
August 1, 2024
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera